Australia appears to be gain access to potentially transformative medication for excess weight: Retatrutide. The dual molecule – working on both GLP-1 and GIP receptors – shows promising efficacy in international research, pointing to meaningful reductions in body fat. While approval hasn't occurred with the Therapeutic Goods Administration (TG… Read More